AK-154

N/A

Report date: 2026/05/12 09:17:32

Base Information

Drug NameAK-154
Drug Alias NameAK-154
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine > personalized mRNA cancer vaccines
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPancreatic NeoplasmsCarcinoma, Pancreatic Ductal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAkeso Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAkeso Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsCarcinoma, Pancreatic Ductal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A